4.8 Article

Attrition-Enhanced Deracemization of the Antimalaria Drug Mefloquine

Journal

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
Volume 58, Issue 6, Pages 1670-1673

Publisher

WILEY-V C H VERLAG GMBH
DOI: 10.1002/anie.201811289

Keywords

chirality; deracemization; drug discovery; medicinal chemistry; synthetic methods

Ask authors/readers for more resources

Mefloquine is an important drug for prevention and treatment of malaria. It is commercially available as a racemic mixture, wherein only one enantiomer is active against malaria, while the other one causes severe psychotropic effects. By converting the drug into a compound that crystallizes as a racemizable racemic conglomerate, the deracemization of mefloquine into the desired enantiomer was achieved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available